Jason D. Harry, Ph.D.

Founder and CEO, Lucidux

Lucidux is an early-stage medical device company developing advanced imaging technologies for minimally invasive surgery. Previously, he was founder and CEO of Afferent Corporation, which focused on neurostimulation technologies to treat chronic dysfunction stemming from stroke, aging, and diabetes. Prior to founding Afferent, he was VP of Research Engineering at NMT Medical, Inc., Boston, MA, a company in the field of minimally invasive cardiovascular implants.